Bacteriuria and antibiotic use during the third wave of COVID-19 intensive care in Sweden
Our findings underscore the complexity of bacteriuria in ICU patients, advocating for targeted surveillance and tailored antibiotic approaches to mitigate UTI risk. Insights into antibiotic use and bacterial colonisation are vital for optimising stewardship practices, combating antimicrobial resistance, and enhancing ICU patient outcomes.
Authors
- Philip A. Karlsson (ORCID: https://orcid.org/0000-0003-0060-005X)
- Michael Hultström (ORCID: https://orcid.org/0000-0003-4675-1099)
- Miklós Lipcsey (ORCID: https://orcid.org/0000-0002-1976-4129)
- Josef D. Järhult (ORCID: https://orcid.org/0000-0002-7075-1059)
- Robert Frithiof (ORCID: https://orcid.org/0000-0003-2278-7951)
- Helen Wang (ORCID: https://orcid.org/0000-0003-4757-1583)
- C A Bolin
- Labolina Spång
Institutions
- Uppsala University (SE)
- Institut de Biologie Intégrative de la Cellule (FR)
Publication Details
- Journal
- Infectious Diseases
- Published
- 2024-11-07
- DOI
- https://doi.org/10.1080/23744235.2024.2423884
- Citations
- 1
- Primary Topic
- Urinary Tract Infections Management
- Type
- article
- Field-Weighted Citation Impact
- 0.39
Funders
- Svenska Sällskapet för Medicinsk Forskning
- Hjärt-Lungfonden
- Vetenskapsrådet
- Science for Life Laboratory